Clinical Trial

Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy

Study acronym: FRONTEDGE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to collect data in clinical practice on the clinical profile of patients treated with Tezepelumab from Q1 2024 to Q1 2025 according to the approved and reimbursed indication in Italy
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-21
Trial Details
NCT Number NCT06948396
Lead Sponsor AstraZeneca
Conditions Asthma
Enrollment 315 participants
Start Date 2025-06-25
Primary Completion 2027-05-30 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-20